Assignee
ETERNITY BIOSCIENCE INC
US·3 granted patents·9 pending applications·12 citations·filing 2013–2021
Top patents by PatentIndex Score
12 records- 0186US9951077B2Aminopyridazinone compounds as protein kinase inhibitorsETERNITY BIOSCIENCE INC·Filed 2014·Granted Apr 24, 2018·9 cites·3 claims
- 0275US10144737B2Substituted ethynyl heterobicyclic compounds as tyrosine kinase inhibitorsETERNITY BIOSCIENCE INC·Filed 2014·Granted Dec 4, 2018·3 cites·12 claims
- 0354US2022135539A1Biaryl amide compounds, preparation methods and medical applications thereofETERNITY BIOSCIENCE INC·Filed 2021·Application pending·0 cites
- 0454US2022144842A1Irak inhibitors, preparation method and medicinal uses thereofETERNITY BIOSCIENCE INC·Filed 2021·Application pending·0 cites
- 0554US2022177446A1Alkyne compounds as irak inhibitors, preparation methods and medicinal uses thereofETERNITY BIOSCIENCE INC·Filed 2021·Application pending·0 cites
- 0654US2022213086A1Azole compounds as irak inhibitors, preparation methods and medicinal uses thereofETERNITY BIOSCIENCE INC·Filed 2021·Application pending·0 cites
- 0750US2022009910A1Tyrosine kinase 2 inhibitors, preparation methods and medicinal uses thereofETERNITY BIOSCIENCE INC·Filed 2021·Application pending·0 cites
- 0850US2022169645A1Compounds as bruton tyrosine kinase inhibitors, preparation methods and medical applications thereofETERNITY BIOSCIENCE INC·Filed 2021·Application pending·0 cites
- 0950US2022002267A1Tyrosine kinase 2 inhibitors, preparation methods and medicinal uses thereofETERNITY BIOSCIENCE INC·Filed 2021·Application pending·0 cites
- 1049US2022009909A1Adamts inhibitors, preparation methods and medicinal uses thereofETERNITY BIOSCIENCE INC·Filed 2021·Application pending·0 cites
- 1144US9458140B2Furanone compounds as kinase inhibitorsETERNITY BIOSCIENCE INC·Filed 2014·Granted Oct 4, 2016·0 cites·31 claims
- 1242US2016257676A1Aminoisoquinoline Derivatives as Protein Kinase InhibitorsETERNITY BIOSCIENCE INC·Filed 2013·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →